Exploratory study of new diagnostic markers in small cell lung cancer

小细胞肺癌新诊断标志物的探索性研究

• 批准号: 20K16378
• 负责人: Sakakibara Rie
• 金额: $ 1.66万
• 依托单位: Tokyo Medical and Dental University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Early-Career Scientists
• 财政年份: 2020
• 资助国家: 日本
• 起止时间: 2020-04-01 至 2023-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-20K16378/
• 关键词: 肺小細胞癌; INSM1; 診断マーカー; 免疫染色; 肺神経内分泌腫瘍; 診断マー カー; 小細胞癌; 神経内分泌腫瘍（LCNEC）; カルチノイド; バイオマーカー; 病理

项目成果

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042)

接受血液透析的肺癌患者化疗的真实结果：多中心回顾性队列研究 (NEJ-042)

• DOI: 10.1016/j.lungcan.2022.07.009
• 发表时间: 2022
• 影响因子: 5.3
• 作者: Minegishi Yuji;Sakakibara Rie;Seike Masahiro et al
• 通讯作者: Seike Masahiro et al

Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy

免疫治疗期间易发生血栓栓塞的转移性肺癌患者概况

• DOI: 10.1016/j.ctarc.2022.100547
• 发表时间: 2022
• 作者: Endo Satoshi;Honda Takayuki;Kawahara Tatsuo;Sakakibara Rie;Mitsumura Takahiro;Okamoto Tsukasa;Miyazaki Yasunari
• 通讯作者: Miyazaki Yasunari

Insulinoma-associated protein 1 (INSM1) is a better marker for the diagnosis and prognosis estimation of small cell lung carcinoma than neuroendocrine phenotype markers such as chromogranin A, synaptophysin and CD56.

胰岛素瘤相关蛋白1（INSM1）是比嗜铬粒蛋白A、突触素和CD56等神经内分泌表型标记物更好的小细胞肺癌诊断和预后评估标记物。

• DOI: 10.1097/pas.0000000000001444
• 发表时间: 2020
• 影响因子: 5.6
• 作者: Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N;Ishikawa Y.
• 通讯作者: Ishikawa Y.